Loading patent…
OwnerAlain Martininventor
Estimating the term…
A method for treating the disease state in mammals caused by mammalian cells involved in the inflammatory response is disclosed. Mammalian cells participating in the inflammatory response are contacted with an inflammatory suppressor selected from the group consisting of alpha-keto acids and their salts which reduce the undesired inflammatory response and is an antioxidant. The inflammatory suppressor may further provide a cellular energy source and be a building block in the cellular synthesis of other cellular components. Compositions for reducing and treating undesired inflammatory response such as pain, swelling, erythema, crusting, scarring, itching, also disclosed.
A method for treating wounds, injuries, diseases and dermatological disease states in mammals caused by mammalian cells involved in the inflammatory response comprising contacting the mammalian cells with an antioxident inflammatory suppressor compound selected from the group consisting of alpha-keto acids used singly or in combination in an amount capable of reducing the undesired inflammatory conditions.
A pharmaceutical composition for the reduction and treatment of a disease state in mammals caused by an undesired inflammatory response comprising an effective amount of an inflammatory suppressor compound selected from the group comprising alpha-keto acids incorporated in a pharmaceutically acceptable carrier composition.
Dependencies are inferred from the claim text.